Notice of Senior Executive Service Performance Review Board Membership, 64948 [2011-26965]
Download as PDF
<![CDATA[
emcdonald on DSK5VPTVN1PROD with NOTICES
64948
Federal Register / Vol. 76, No. 202 / Wednesday, October 19, 2011 / Notices
Marija Manojlovic, University of
Pittsburgh: Based on an inquiry
conducted and written admission
obtained by the University of Pittsburgh
(UP) and additional analysis conducted
by ORI in its oversight review, ORI
found that Ms. Marija Manojlovic,
former graduate student, Department of
Chemistry, UP, engaged in research
misconduct in research supported by
National Institute of General Medical
Sciences (NIGMS), National Institutes of
Health (NIH), grant P50 GM067082,
National Cancer Institute (NCI), NIH,
grant P01 CA078039, National Institute
of Mental Health (NIMH), NIH, grant
U54 MH074411, and National Institute
of Allergy and Infectious Diseases
(NIAID), NIH, grant R01 AI033506.
ORI found that the Respondent
engaged in research misconduct by
falsifying and fabricating the synthesis
and spectral data that were included in
one (1) poster presentation and in one
(1) pre-submission draft of a paper to be
submitted for publication.
Specifically, ORI found that the
Respondent knowingly falsified and
fabricated the synthesis and
characterization, largely in the form of
manipulated 1H- and 13C–NMR spectral
data, for five intermediate steps and the
final product, 9-desmethylpleurotin,
and presented these false results in a
poster, ‘‘Efforts Towards the Total
Synthesis of Pleurotin,’’ presented at the
2011 National Organic Symposium, and
in a manuscript, ‘‘Total Synthesis of 9desmethylpleurotin,’’ prepared for
submission to Angewandte Chemie
International Edition.
Ms. Manojlovic has voluntarily agreed
for a period of three (3) years, beginning
on September 26, 2011:
(1) To have her U.S. Public Health
Service (PHS)-supported research
supervised; Respondent agreed that
prior to the submission of an
application for PHS support for a
research project on which her
participation is proposed and prior to
her participation in any capacity on
PHS-supported research, she shall
ensure that a plan for supervision of her
duties is submitted to ORI for approval;
the supervision plan must be designed
to ensure the scientific integrity of her
research contribution; Respondent
agreed that she shall not participate in
any PHS-supported research until such
a supervision plan is submitted to and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon supervision plan;
(2) That any institution employing her
shall submit, in conjunction with each
application for PHS funds, or report,
manuscript, or abstract involving PHSsupported research in which she is
VerDate Mar<15>2010
16:34 Oct 18, 2011
Jkt 226001
involved, a certification to ORI that the
data provided by Respondent are based
on actual experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract; and
(3) To exclude herself from serving in
any advisory capacity to PHS including,
but not limited to, service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John Dahlberg,
Director, Division of Investigative Oversight,
Office of Research Integrity.
[FR Doc. 2011–27022 Filed 10–18–11; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Decision To Evaluate a Petition To
Designate a Class of Employees From
Oak Ridge National Laboratory (X–10),
Oak Ridge, TN, To Be Included in the
Special Exposure Cohort
National Institute for
Occupational Safety and Health
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
HHS gives notice as required
by 42 CFR 83.12(e) of a decision to
evaluate a petition to designate a class
of employees from Oak Ridge National
Laboratory (X–10), Oak Ridge,
Tennessee, to be included in the Special
Exposure Cohort under the Energy
Employees Occupational Illness
Compensation Program Act of 2000. The
initial proposed definition for the class
being evaluated, subject to revision as
warranted by the evaluation, is as
follows:
Facility: Oak Ridge National
Laboratory (X–10)
Location: Oak Ridge, Tennessee.
Job Titles and/or Job Duties: All
contractor employees, subcontractor
employees, and AEC employees who
were monitored or should have been
monitored for any of the various
radionuclides and fission products
present at the X–10 plant.
Period of Employment: January 1,
1943 through December 31, 1952.
FOR FURTHER INFORMATION CONTACT:
Stuart L. Hinnefeld, Director, Division
of Compensation Analysis and Support,
National Institute for Occupational
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 9990
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone 877–
222–7570. Information requests can also
be submitted by e-mail to
DCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. 2011–27035 Filed 10–18–11; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Senior Executive Service
Performance Review Board
Membership
The Agency for Healthcare Research
and Quality (AHRQ) announces the
appointment of members to the AHRQ
Senior Executive Service (SES)
Performance Review Board (PRB). This
action is being taken in accordance with
5 U.S.C. 4314(c)(4), which requires
notice of appointment of members to
performance review boards to be
published in the Federal Register.
Members of the PRB are appointed in
a manner that will ensure consistency,
stability and objectivity in the SES
performance appraisals. The function of
the PRB is to make recommendations to
the Director, AHRQ, relating to the
performance of senior executives in the
Agency.
The following persons will serve on
the AHRQ SES Performance Review
Board:
Irene Fraser, Stephen B. Cohen, William
Munier, David Meyers, Michael
Fitzmaurice, Phyllis Zucker, Mark
Handelman, Jean Slutsky.
For further information about the
AHRQ Performance Review Board,
contact Ms. Alison Reinheimer, Office
of Performance, Accountability,
Resources, and Technology, Agency for
Healthcare Research and Quality, 540
Gaither Road, Suite 4012, Rockville,
Maryland 20850.
Dated: October 2, 2011.
Carolyn M. Clancy,
Director, AHRQ.
[FR Doc. 2011–26965 Filed 10–18–11; 8:45 am]
BILLING CODE 4160–90–M
E:\FR\FM\19OCN1.SGM
19OCN1
]]>Agencies
[Federal Register Volume 76, Number 202 (Wednesday, October 19, 2011)]
[Notices]
[Page 64948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-26965]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Senior Executive Service Performance Review Board
Membership
The Agency for Healthcare Research and Quality (AHRQ) announces the
appointment of members to the AHRQ Senior Executive Service (SES)
Performance Review Board (PRB). This action is being taken in
accordance with 5 U.S.C. 4314(c)(4), which requires notice of
appointment of members to performance review boards to be published in
the Federal Register.
Members of the PRB are appointed in a manner that will ensure
consistency, stability and objectivity in the SES performance
appraisals. The function of the PRB is to make recommendations to the
Director, AHRQ, relating to the performance of senior executives in the
Agency.
The following persons will serve on the AHRQ SES Performance Review
Board:
Irene Fraser, Stephen B. Cohen, William Munier, David Meyers, Michael
Fitzmaurice, Phyllis Zucker, Mark Handelman, Jean Slutsky.
For further information about the AHRQ Performance Review Board,
contact Ms. Alison Reinheimer, Office of Performance, Accountability,
Resources, and Technology, Agency for Healthcare Research and Quality,
540 Gaither Road, Suite 4012, Rockville, Maryland 20850.
Dated: October 2, 2011.
Carolyn M. Clancy,
Director, AHRQ.
[FR Doc. 2011-26965 Filed 10-18-11; 8:45 am]
BILLING CODE 4160-90-M
